Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure of information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Meeting with Investors/Analysts Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Disclosure under Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of post results earning conference call held on February 3, 2023 Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation- unaudited financial results for the quarter and nine months ended December 31, 2022 of Thyrocare Technologies Limited Thyrocare Technologies Ltd - 539871 - Unaudited Financial Results For The Quarter And Nine Months Ended On December 31, 2022.
Unaudited financial Results for the quarter and nine months ended on December 31, 2022. Thyrocare Technologies Ltd - 539871 - Board Meeting Outcome for Outcome Of Board Meeting Of Thyrocare Technologies Limited Held On February 3, 2023
Outcome of board meeting of Thyrocare Technologies Limited held on February 3, 2023 Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to intimate that a conference call for the analysts is arranged by our management to discuss the Company's financial results for quarter / nine months ended December 31, 2022, on Friday, February 3, 2023 at 6.00 pm. (IST). Thyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Approval Of Unaudited Stand-Alone And Consolidated Financial Results Of The Company For The Quarter / Nine Months Ended December 31, 2022.
Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2023 ,inter alia, to consider and approve Board Meeting intimation Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst/Investor Meet Thyrocare Technologies Ltd - 539871 - Closure Of Trading Window
Intimation of closure of trading window under the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015